Cunninghamella as a Microbiological Model for Metabolism of Histamine H3 Receptor Antagonist 1-[3-(4-tert-Butylphenoxy)propyl]piperidine
Open Access
- 16 September 2012
- journal article
- research article
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 168 (6) , 1584-1593
Abstract
The aim of the study was to analyze the ability of the microorganism Cunninghamella to carry out the biotransformation of 1-[3-(4-tert-butylphenoxy)propyl]piperidine (DL76) and to compare the obtained results with in silico models. Biotransformation was carried out by three strains of filamentous fungus: Cunninghamella echinulata, Cunninghamella blakesleeana, and Cunninghamella elegans. Most probable direction of DL76 metabolic transition was the oxidation of the methyl group in the tert-butyl moiety leading to the formation of the metabolite with I° alcohol properties. This kind of reaction was conducted by all three strains tested. However, only in the case of C. blakesleeana that biotransformation product had a structure of carboxylic acid. CYP2C19 was identified by Metasite software to be the isoform of major importance in the oxidation process in the tert-butyl moiety of DL76. In silico data coincide with the results of experiments conducted in vitro. It was confirmed that Cunninghamella fungi are a very good model to study the metabolism of xenobiotics. The computational methods and microbial models of metabolism can be used as useful tools in early ADME-Tox assays in the process of developing new drug candidates.Keywords
This publication has 35 references indexed in Scilit:
- Structure-Based Prediction of Subtype Selectivity of Histamine H3 Receptor Selective Antagonists in Clinical TrialsJournal of Chemical Information and Modeling, 2011
- Developments on drug discovery and on new therapeutics: highly diluted tinctures act as biological response modifiersBMC Complementary and Alternative Medicine, 2011
- A Critical Analysis of the Interplay between Cytochrome P450 3A and P-Glycoprotein: Recent Insights from Knockout and Transgenic MicePharmacological Reviews, 2011
- LC–MS–MS Method for the Analysis of New Non-Imidazole Histamine H3 Receptor Antagonist 1-[3-(4-tert-Butylphenoxy)propyl]piperidine in Rat Serum—Application to Pharmacokinetic StudiesChromatographia, 2011
- Production of human metabolites of the anti-cancer drug flutamide via biotransformation in Cunninghamella speciesBiotechnology Letters, 2010
- Metabolism of Methoxychlor byCunninghamella elegansATCC36112Journal of Agricultural and Food Chemistry, 2009
- Cunninghamella – A microbial model for drug metabolism studies – A reviewBiotechnology Advances, 2009
- Transformation of Verapamil byCunninghamella blakesleeanaApplied and Environmental Microbiology, 2004
- A Model for Predicting Likely Sites of CYP3A4-mediated Metabolism on Drug-like MoleculesJournal of Medicinal Chemistry, 2003
- An in Vitro Reporter Gene Assay Method Incorporating Metabolic Activation with Human and Rat S9 or Liver MicrosomesBiochemical and Biophysical Research Communications, 2001